Rheumatology in Scranton, PA
3 verified rheumatology doctors in Scranton.
Rheumatologists treat autoimmune and inflammatory conditions affecting the joints, muscles, and connective tissue.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Pennsylvania State Board of Medicine
Dr. Julio Ramos, MD
Rheumatology
CMS Open Payments· $26,239 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$26,239
Total received
91
Transactions
15
Paying companies
Top paying companies
Among the 6,451 rheumatology doctors we've analyzed, about 56% received any industry payment (median $958 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US rheumatology doctors.
Payments to Julio Ramos do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mark Cruciani, MD
Rheumatology
CMS Open Payments· $701.19 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$701.19
Total received
32
Transactions
12
Paying companies
Top paying companies
Among the 6,451 rheumatology doctors we've analyzed, about 56% received any industry payment (median $958 among those who did). This doctor's total ranks around the 69th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US rheumatology doctors.
Payments to Mark Cruciani do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Emily Keeler, DO
Rheumatology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.